e-learning
resources
Munich 2014
Monday, 08.09.2014
Tuberculosis: diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antimicrobial peptide cathelicidin (LL- 37) and human beta-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis
E. Cakir, E. Torun, A. H. Gedik, T. Umutoglu, E. C. Aktas, U. Topuz, G. Deniz (Istanbul, Turkey)
Source:
International Congress 2014 – Tuberculosis: diagnosis
Session:
Tuberculosis: diagnosis
Session type:
Thematic Poster Session
Number:
2596
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Cakir, E. Torun, A. H. Gedik, T. Umutoglu, E. C. Aktas, U. Topuz, G. Deniz (Istanbul, Turkey). Antimicrobial peptide cathelicidin (LL- 37) and human beta-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis. Eur Respir J 2014; 44: Suppl. 58, 2596
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Cathelicidin (LL-37) ve human β2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015
Neutrophils increase M. tuberculosis growth in a human lung model
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Yield of routine culture of bronchoalveolar lavage fluid for tuberculosis in a low prevalence setting
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Role of bronchoalveolar lavage in new sputum smear negative pulmonary tuberculosis patients
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
Comparison of yield of acid fast bacilli (AFB) from induced sputum versus gastric lavage for diagnosis of pulmonary tuberculosis in children
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Genotype MTBDR
plus
Line Probe Assay as a rapid tool for the diagnosis of smear-negative tuberculosis in bronchoalveolar lavage fluid in Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Antimicrobial peptides cathelicidin (LL-37) ve human beta2 defensin levels of pediatric patients with bronchiolitis obliterans
Source: International Congress 2014 – Respiratory infections in children
Year: 2014
High diagnostic accuracy of immunodiagnosis in sputum smear/PCR-negative pulmonary tuberculosis
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Rapid diagnosis of smear negative pulmonary tuberculosis by enumeration of MTB-specific mononuclear cells from the bronchoalveolar lavage (BAL)
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006
Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Inflammatory cytokine levels in serum and bronchoalveolar lavage fluid and gene polymorphism in young adult patients with bronchiectasis
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Bronchoalveolar lavage fluid cytokines(TNF-α, IL-2, IFN-γ) in Turkish patients with smear negative pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 33s
Year: 2004
Interleukin 27 (IL27) as antitumor tool? Results from bronchoalveolar lavage (BAL) examination
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Immune responses in lungs of patients with tuberculous pleural effusion without pulmonary tuberculosis
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Clinical significance of
Mycobacterium tuberculosis
(MBT) DNA detection in bronchoalveolar lavage and bronchial biopsy in HIV-infected patients
Source: Eur Respir J 2005; 26: Suppl. 49, 690s
Year: 2005
Intracellular cytokine and cathelicidin secretion from monocytes and neutrophils in childhood lung tuberculosis and its relationship with vitamin D levels
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Profile of antimicrobial peptides in the bronchoalveolar lavage of patients with interstitial lung diseases
Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis
Year: 2021
Protracted bacterial bronchitis and malacias: Which came first , the chicken or the egg?
Source: International Congress 2014 – Paediatric bronchology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept